Zymeworks Inc. (ZYME) Financials

ZYME Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 397.0 billion 316.6 billion
March 31, 2026 478.2 million 314.6 million
Dec. 31, 2025 346.5 million 78.0 million
Sept. 30, 2025 397.3 million 77.2 million

ZYME Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -31.9 million 11.3 million
March 31, 2026 -45.7 million 6.9 million
Dec. 31, 2025 -10.6 million -3.4 million
Sept. 30, 2025 -31.8 million 6.9 million

ZYME Net Income

No data available :(

ZYME Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 270.7 billion 12.7 billion 12.7 million
March 31, 2026 364.7 million - 13.8 million
Dec. 31, 2025 228.8 million - 18.3 million
Sept. 30, 2025 251.9 million - 15.5 million

ZYME Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 73.0 million
March 31, 2026 74.7 million
Dec. 31, 2025 75.3 million
Sept. 30, 2025 75.8 million

ZYME Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 216000 32.0 million 19.3 million -
March 31, 2026 216000 2.4 billion 15.1 billion -
Dec. 31, 2025 569895 31.2 million 13.7 million -
Sept. 30, 2025 410000 35.6 million 14.1 million -

ZYME Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 4.6 million -
March 31, 2026 2.4 million 2.8 million
Dec. 31, 2025 2.5 million 1.7 million
Sept. 30, 2025 27.6 million -

ZYME Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ZYME

Price: $25.15

52 week price:
16.00
31.34

Earnings Per Share: -2.07 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 105946

Ebitda: -15.5 million

Market Capitalization: 1.9 billion

Links: